Thursday, December 30, 2010

Asthma Med Primatene Mist Being Reformulated

Because its propellant is a chloroflourocarbon,Primatene Mist is being reformulated by Armstrong Pharmaceuticals.As of December 31,2011,the Food and Drug Administration is banning the production and sale of epinephrine metered dose inhalers containing CFCs to protect the atmosphere's ozone layer.
Primatene Mist,introduced in 1964,is the only inhalable over the counter medication for the temporary relief of occasional symptoms of bronchial asthma.Although Primatene Mist will have a new,non-CFC propellant,its active ingredient will remain epinephrine.
Primatene Mist relieves wheezing,tightness of chest and shortness of breath in as little as 15 seconds.It is the number one OTC brand for physician-diagnosed bronchial asthma.
The Primatene brand is also applied to OTC tablets,sold since 1954,which ease breathing for asthma patients by reducing spasms of bronchial muscles,loosening phlegm and thinning bronchial secretions.Highly regarded by patients,Primatene tablets are a product of Pfizer Consumer Healthcare and have different active ingredients than Primatene Mist.
Pfizer(PFE)

3 comments:

Anonymous said...

you need to reformulate the alternatives are not as effective and getting perscriptions are time consuming it was too easy to get at the grocery store i have used it for 45 years with no side affectsand the pills take too long to act

Anonymous said...

When will the new reformulation be available?

Anonymous said...

I second that, do we know when the mist will come back our? The pills are definitely helpful but in no way as immediate a relief as the mist. Thanks! We miss you, inhalers!